# CRESCENT BIOPHARMA, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/crescent-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 10 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:38.263568+00:00 | | Last reviewed | 2026-10-16T13:52:38.263568+00:00 | ## Identity - Legal name: CRESCENT BIOPHARMA, INC. - Display name: CRESCENT BIOPHARMA, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T01:01:29.580043+00:00 | | Completeness | 0.409 | | Record Quality | 0.844 | | Directors | 7 | | Committees | 4 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alexandra Balcom: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:5 - David Lubner: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:6 - Jonathan Violin, Ph.D.: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:7 - Joshua Brumm: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:8 - Peter Harwin: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:9 - Susan Moran, M.D., MSCE: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:10 - Alexandra Balcom: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member); Compensation (member). claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_record:18 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Alexandra Balcom (member, current); David Lubner (member, current). committee_id=alpha:committee:crescent-biopharma-inc:audit - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: David Lubner (member, current). committee_id=alpha:committee:crescent-biopharma-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Alexandra Balcom (member, current); David Lubner (member, current). committee_id=alpha:committee:crescent-biopharma-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: David Lubner (member, current); Peter Harwin (member, current). committee_id=alpha:committee:crescent-biopharma-inc:nominating-and-governance ## Executive leadership - Barbara Bispham Hale: General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:11 - Ellie Im, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:12 - Jan Pinkas, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:13 - Jonathan McNeill, M.D.: Chief Operating Officer and President [COO]. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:14 - Joshua Brumm: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:15 - Richard Scalzo: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:16 - Ryan Lynch: Treasurer, Senior Vice President of Finance and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:17 ## Governance events - GC_CHANGED: Barbara Bispham Hale executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:17m5y79mzim89 - EXECUTIVE_APPOINTED: Ellie Im, M.D. executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1bv5w54h4798c - EXECUTIVE_APPOINTED: Jan Pinkas, Ph.D. executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:qjxnyi1ot0gcq - EXECUTIVE_APPOINTED: Jonathan McNeill, M.D. executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1jjg9q4nkixgq - CEO_CHANGED: Joshua Brumm executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:12otzgpyypdr1 - CFO_CHANGED: Richard Scalzo executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1skkfgj1b0irp - EXECUTIVE_APPOINTED: Ryan Lynch executive of CRESCENT BIOPHARMA, INC., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:xf6a7wg81w1k - DIRECTOR_APPOINTED: David Lubner seat on CRESCENT BIOPHARMA, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:y72vgjg9ogff - DIRECTOR_APPOINTED: Joshua Brumm seat on CRESCENT BIOPHARMA, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:xrm88p1xms0lh - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of CRESCENT BIOPHARMA, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:z0ax0bvv1f6b - COMMITTEE_MEMBER_ADDED: David Lubner member of Audit; Compensation; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1rnfiv7i3kls5 - DIRECTOR_APPOINTED: Alexandra Balcom seat on CRESCENT BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:1g1j6dj6ao0zh - DIRECTOR_APPOINTED: Jonathan Violin, Ph.D. seat on CRESCENT BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:fx9f951l2kbr - DIRECTOR_APPOINTED: Peter Harwin seat on CRESCENT BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:eh9w0n1u9zfqh - DIRECTOR_APPOINTED: Susan Moran, M.D., MSCE seat on CRESCENT BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:38.263568+00:00. event_id=alpha:event:transition:rr7twx1ase4l9 ## Scoped resources - `alpha://company/crescent-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record - `alpha://company/crescent-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=identity - `alpha://company/crescent-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/crescent-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=board - `alpha://company/crescent-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=committees - `alpha://company/crescent-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=leadership - `alpha://company/crescent-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=ownership - `alpha://company/crescent-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=financials - `alpha://company/crescent-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=capital-structure - `alpha://company/crescent-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=compensation - `alpha://company/crescent-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=governance - `alpha://company/crescent-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/crescent-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=audit - `alpha://company/crescent-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=legal - `alpha://company/crescent-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=risk - `alpha://company/crescent-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=cyber - `alpha://company/crescent-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=ai-governance - `alpha://company/crescent-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=agents - `alpha://company/crescent-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=ecosystem - `alpha://company/crescent-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=events - `alpha://company/crescent-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=relationships - `alpha://company/crescent-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=assessments - `alpha://company/crescent-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:alexandra-balcom","name":"Alexandra Balcom"},"source_id":"board_seats"}` - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:david-lubner","name":"David Lubner"},"source_id":"board_seats"}` - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:alexandra-balcom","name":"Alexandra Balcom"},"source_id":"board_seats"}` - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:david-lubner","name":"David Lubner"},"source_id":"board_seats"}` - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:david-lubner","name":"David Lubner"},"source_id":"board_seats"}` - Claim alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:peter-harwin","name":"Peter Harwin"},"source_id":"board_seats"}` ## Leadership - Alexandra Balcom: Director. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - David Lubner: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - Jonathan Violin, Ph.D.: Director. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - Joshua Brumm: Director. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - Peter Harwin: Director, Nominating and Governance. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - Susan Moran, M.D., MSCE: Director. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5. - Barbara Bispham Hale: General Counsel and Corporate Secretary. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:11. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:688eb9011196d9fd80d89013f2b2a6b9438bf086be93f825e1d11d2e872d7b5e. - Ellie Im, M.D.: Chief Medical Officer. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:12. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba123ad9a67efce5b6d89b35ccbb95cb6bf7fd764ee8c2d666871ef2934fcb8. - Jan Pinkas, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:13. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fb75ac2e87b457f40d70077431c86e85420d16905a5bd168a7e6b4167dca8938. - Jonathan McNeill, M.D.: Chief Operating Officer and President. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:14. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:595f6bf659d675a0ad808a9f753cdf05a180e1aa09baaa6403a2b7099ebe3c90. - Joshua Brumm: Chief Executive Officer and Director. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:15. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:207f013bd574f65f63b5f640190c26a46a878cdc790122034ee6c4c176e254f0. - Richard Scalzo: Chief Financial Officer. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:16. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3068732f0ede473917194c43c5bb661f182a4361e8bc728f2c3a8a5942206a99. - Ryan Lynch: Treasurer, Senior Vice President of Finance and Chief Accounting Officer. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:leadership_role:17. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fdc798f14fd6b1dacf357ac7bcae73db7d1b6d1bc9512feaa928d01351e386cc. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Alexandra Balcom; David Lubner. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - Compensation: Chair not stated; Members Alexandra Balcom; David Lubner. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - Nominating and Governance: Chair not stated; Members David Lubner; Peter Harwin. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - CRESCENT BIOPHARMA, INC.. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75a830de37d02d86a09c46da2d7082cfad41ab0ff0c02814c047eae4b1e9d441. ## Entity Status - Public listing published. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75a830de37d02d86a09c46da2d7082cfad41ab0ff0c02814c047eae4b1e9d441. ## Published Fact - US. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75a830de37d02d86a09c46da2d7082cfad41ab0ff0c02814c047eae4b1e9d441. ## Committee Appointment - Alexandra Balcom: member, Audit. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - David Lubner: member, Audit. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - Alexandra Balcom: member, Compensation. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - David Lubner: member, Compensation. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - David Lubner: member, Nominating and Governance. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. - Peter Harwin: member, Nominating and Governance. Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690. ## Security Listing - CBIO (NASDAQ). Claim: alpha:claim:company:c34db3e0-aefe-4829-8c31-ebb1800d89e5:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75a830de37d02d86a09c46da2d7082cfad41ab0ff0c02814c047eae4b1e9d441. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:75a830de37d02d86a09c46da2d7082cfad41ab0ff0c02814c047eae4b1e9d441: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/crescent-biopharma-inc). - alpha:projection-evidence:document:bcb69b3f34ea51e6a3160fe8c605df5b7a91a18d78aa1b59ffd051d69c8d05b5: [CRESCENT BIOPHARMA, INC. DEF 14A 2026-04-21](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:688eb9011196d9fd80d89013f2b2a6b9438bf086be93f825e1d11d2e872d7b5e: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:fba123ad9a67efce5b6d89b35ccbb95cb6bf7fd764ee8c2d666871ef2934fcb8: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:fb75ac2e87b457f40d70077431c86e85420d16905a5bd168a7e6b4167dca8938: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:595f6bf659d675a0ad808a9f753cdf05a180e1aa09baaa6403a2b7099ebe3c90: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:207f013bd574f65f63b5f640190c26a46a878cdc790122034ee6c4c176e254f0: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:3068732f0ede473917194c43c5bb661f182a4361e8bc728f2c3a8a5942206a99: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:document:fdc798f14fd6b1dacf357ac7bcae73db7d1b6d1bc9512feaa928d01351e386cc: [CBIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). - alpha:projection-evidence:9e0932f31776c2012fd0e253b7498759326eb97fadf097199ed283f92b2da690: [Audit](https://www.sec.gov/Archives/edgar/data/1253689/000162828026026282/cbio-20260421.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/crescent-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/crescent-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/crescent-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/crescent-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T01:01:29.382847+00:00; recorded 2026-10-17T01:01:29.382847+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.